Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of the End-tidal Carbon Dioxide (EtCO2 ) as a Severity Criterion in COPD Exacerbations: a Prospective Observational Study

NCT05704881 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05704881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05704881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of the End-tidal Carbon Dioxide (EtCO2 ) as a Severity Criterion in COPD Exacerbations: a Prospective Observational Study
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2023
Completion date
December 3, 2026
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

exacerbation copd, pulmonary disease, chronic obstructive